NY S 9523
in committeeRelates to coverage for treatments to slow the progression of Alzheimer's disease and related dementias
New York · 2025-2026 Regular Session · upper
Quick answers
Did NY S 9523 pass?
Not yet. NY S 9523 is in committee as of 2026-03-19 and has not come to a final vote. Latest recorded action (2026-03-19): REFERRED TO INSURANCE
What is NY S 9523 about?
Provides for coverage for treatments to slow the progression of Alzheimer's disease and related dementias.
Who sponsors NY S 9523?
Cordell Cleare is the primary sponsor of NY S 9523, joined by 5 cosponsors.
Description
Provides for coverage for treatments to slow the progression of Alzheimer's disease and related dementias.
- Introduced
- —
- Latest action
- 2026-03-19 — REFERRED TO INSURANCE
- Bill type
- bill
- Last updated
- —
Sponsors
- Cordell Cleareprimary
- Joseph P. Addabbo Jr.cosponsor
- Kristen Gonzalezcosponsor
- Pete Harckhamcosponsor
- Kevin S. Parkercosponsor
- James Skoufiscosponsor
Committees
Not provided by source.
Action timeline
2026-03-19
REFERRED TO INSURANCE
referral-committee
Versions
- S9523Compare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: A 10748
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 9523. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.